Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

This study has been completed.

Study NCT00448253 Information provided by Cangene Corporation

First Received: March 14, 2007 Last Updated: January 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2008
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)